Erkut Bahceci

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

Richard Childs, Allen Chernoff, Nathalie Contentin et al. · New England Journal of Medicine · 2000 · 1K citations · Full text

Medicine, Hematology, Oncology +15

Engraftment Kinetics After Nonmyeloablative Allogeneic Peripheral Blood Stem Cell Transplantation: Full Donor T-Cell Chimerism Precedes Alloimmune Responses

Richard Childs, Emmanuel Clave, Nathalie Contentin et al. · Blood · 1999 · 528 citations

Medicine, Hematology, Immunology +12

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes et al. · The Lancet Oncology · 2017 · 488 citations · Full text

Medicine, Oncology, Pharmacology +10

Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease

Partow Kebriaei, Luis Isola, Erkut Bahceci et al. · Biology of Blood and Marrow Transplantation · 2009 · 433 citations · Full text

Pharmacy, Immunology, Cell Therapy +16